These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3041936)

  • 21. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of long-term treatment with low doses of carteolol on cardiovascular regulatory functions in elderly patients with mild hypertension.
    Shimada K; Kawamoto A; Matsubayashi K; Chikamori T; Kuzume O; Ozawa T
    Clin Ther; 1990; 12(2):118-24. PubMed ID: 1972351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carteolol treatment of essential hypertension: a long-term study of safety and efficacy.
    Luther RR; Maurath CJ; Klepper MJ; Peckinpaugh RO; Ringham GL
    J Int Med Res; 1986; 14(4):175-84. PubMed ID: 3758467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia].
    Lohmöller G; Middeke M; Mrowka C; Pötzl C; Renner W; Zoller W
    Med Klin (Munich); 1989 Feb; 84(2):81-5. PubMed ID: 2651861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics].
    Hugues FC; Le Jeunne C; Munera Y; Dufier JL
    J Fr Ophtalmol; 1987; 10(8-9):485-90. PubMed ID: 2892874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.
    Dahlöf B; Danielson M; Andersson O; Thulin T; Ohman P; Mörlin C; Boberg J; Karlberg BE; Jern S; Hansson L
    Br J Clin Pharmacol; 1984 Dec; 18(6):831-6. PubMed ID: 6152175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
    Simon H; Schuppan U
    Arzneimittelforschung; 1983; 33(2a):318-21. PubMed ID: 6340700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pafenolol in hypertension: a double-blind randomized trial of a new beta 1-selective adrenoceptor blocker.
    Dahlöf B; Sjöberg KH; Flygt C; Jern S; Hansen S; Hansson L
    J Cardiovasc Pharmacol; 1986; 8(1):55-9. PubMed ID: 2419693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta 2-adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: an in vivo study.
    Bruck H; Poller U; Lüssenhop H; Pönicke K; Temme T; Heusch G; Philipp T; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):361-8. PubMed ID: 15526107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Local anesthetic effect and subjective tolerance of 2% carteolol and 0.6% metipranolol on healthy eyes].
    Höh H
    Klin Monbl Augenheilkd; 1989 Apr; 194(4):241-8. PubMed ID: 2566707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative long-term vasoactive effects of atenolol and carteolol on the properties of the small and large arteries of the upper extremities in human essential hypertension.
    Merli IP; Levenson J; Filitti V; Simon A
    Clin Pharmacol Ther; 1989 Dec; 46(6):686-92. PubMed ID: 2689046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carteolol hydrochloride: controlled evaluations of its ocular hypotensive efficacy relative to its vehicle, and, in combination with pilocarpine, relative to timolol.
    Keates EU; Friedland BR; Stewart RH; Mandell AI
    J Glaucoma; 1994; 3(4):315-22. PubMed ID: 19920616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A long term clinical trial of carteolol in the management of glaucoma. Belgian Carteolol Study Participants.
    Vercruysse K; Goethals M; Vandeputte O; Missotten L
    Bull Soc Belge Ophtalmol; 1992; 245():75-80. PubMed ID: 1344751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure.
    Duff GR; Graham PA
    Br J Ophthalmol; 1988 Jan; 72(1):27-8. PubMed ID: 3277664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol.
    Saxenhofer H; Morger D; Weidmann P; Ferrier C; Shaw SG
    J Hypertens; 1991 Nov; 9(11):1049-56. PubMed ID: 1661763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of indenolol treatment on beta-adrenergic receptors of polymorphonucleates in essential hypertension.
    Corradi L; Groothold G; Venco A; Mailland F; Negri F; Grandi A; Barzizza F; Finardi G
    J Hypertens Suppl; 1986 Dec; 4(6):S137-40. PubMed ID: 2886569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.